Bauer Jake Insider Trades

Insider Trading History

Track insider trading activity for Bauer Jake. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunovant
Immunovant IMVT
Director
Holding Value $1.31M 38,896 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$515k 20,941 shares
$24.61
$33.65
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $791k 17,126 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 17,126 shares
$27.16
$46.21
Helix Acquisition II
Helix Acquisition II HLXB
Director
Holding Value $1.37M 138,193 shares
Last Trade
Aug 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.33M 138,193 shares
$9.59
$9.90
Immunovant
Immunovant IMVT
Director
Holding Value $1.19M 35,234 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 35,234 shares
$15.90
$33.65
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $947k 20,491 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 20,491 shares
$22.47
$46.21
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $778k 16,835 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 16,835 shares
$14.85
$46.21
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.08M 23,364 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$347k 23,364 shares
$14.85
$46.21
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.27M 27,567 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$697k 27,567 shares
$25.28
$46.21
Imara
Imara IMRA
Director
Holding Value $1.27M 87,372 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$664k 105,078 shares
$6.32
$14.59
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $818k 17,706 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 17,706 shares
$25.28
$46.21
Imara
Imara IMRA
Director
Holding Value $402k 27,567 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 27,567 shares
$6.32
$14.59
ARYA Sciences Acquisition V
ARYA Sciences Acquisition V ARYE
Director
Holding Value $0 0 shares
Last Trade
Jul 12, 2021 Sale
No data
No data
$10.36
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $0 0 shares
Last Trade
Jun 04, 2020 Sale
No data
No data
$44.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up